NCT03537937View on ClinicalTrials.gov

Pragmatic Investigation of optimaL Oxygen Targets Trial

NACompletedINTERVENTIONAL
Enrollment

2,541

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

January 31, 2022

Study Completion Date

January 31, 2022

Conditions
Respiratory Failure
Interventions
OTHER

Lower SpO2 Target

SpO2 target 90% (range 88-92%)

OTHER

Intermediate SpO2 Target

SpO2 target 94% (range 92-96%)

OTHER

Higher SpO2 Target

SpO2 target 98% (range 96-100%)

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT03537937 - Pragmatic Investigation of optimaL Oxygen Targets Trial | Biotech Hunter | Biotech Hunter